发明名称 Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154
摘要 The present invention provides methods and materials for treating and preventing autoimmune diseases. In particular, the present invention relates to the discovery that small peptides are capable of interacting with CD40, thereby interfering with the ability of CD40 to interact with CD 154, which is important in inflammation. The present invention also relate to the use of such peptides in reducing the inflammatory response, and in particular, the autoimmune inflammatory response. The present invention also relates to the use of such short peptides to prevent or reverse autoimmune disease, and particular, diabetes, in individuals suffering from such disease. It also relates to methods and materials for detecting T-cells that express CD40 (Th40 cells). Also provided are kits for reducing inflammation, treating autoimmune diseases, or detecting Th40 cells.
申请公布号 US9562088(B2) 申请公布日期 2017.02.07
申请号 US201113880387 申请日期 2011.10.19
申请人 The Regents of the University of Colorado, a body corporate 发明人 Wagner David
分类号 A61K38/00;C07K7/00;C07K14/705;A61K38/08;A61K38/10;A61K38/17 主分类号 A61K38/00
代理机构 Sheridan Ross P.C. 代理人 Sheridan Ross P.C.
主权项 1. A pegylated peptide consisting of SEQ ID NO:8 that inhibits the binding of CD40 with CD154/gp39/CD40-ligand.
地址 Denver CO US